Clinical trial
Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy
NCT00016653 · Cooperative International Neuromuscular Research Group, Other · Completed
Key facts
| NCT number | NCT00016653 |
|---|---|
| Title | Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy |
| Official title | A Multicenter Randomized Placebo-controlled Double-blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy |
| Lead sponsor | Cooperative International Neuromuscular Research Group, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Muscular Dystrophy, Duchenne |
| Intervention type | Drug |
| Interventions | Creatine Monohydrate, Glutamine |
| Enrollment | 48 |
| Start date | Jun 1, 2000 |
| Completion | Dec 1, 2006 |
| First posted | May 23, 2001 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: